RecruitingNCT06177743

IRIS-Coroflex NEO Cohort

Evaluation of Effectiveness and Safety of Coroflex ISAR NEO Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study

Sponsor

Seung-Jung Park

Enrollment

1,000 participants

Start Date

Jan 9, 2025

Study Type

OBSERVATIONAL

Conditions

Coronary artery stenosis Coronary Artery Disease

Summary

The objective of this study is to evaluate the effectiveness and safety of Coroflex ISAR NEO stents in comparison to other drug-eluting stents (DES) in real-world practice.

Eligibility

Min Age: 19 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Coroflex ISAR NEO stent for people with coronary artery disease and coronary artery stenosis. The study is currently recruiting participants at 11 locations. People eligible for this study include aged 19 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICECoroflex ISAR NEO stent

Percutaneous coronary intervention with Coroflex ISAR NEO stent

Locations(11)

Asan Medical Center

Seoul, Songpa-gu, South Korea

Bucheon Sejong Hospital

Bucheon-si, South Korea

The Catholic Univ. of Korea BUCHEON ST.Mary's hospital

Bucheon-si, South Korea

Veterans Hospital

Daegu, South Korea

Chonnam National University Hospital

Gwangju, South Korea

Inje University Ilsan Paik Hospital

Ilsan, South Korea

Myongji Hospital

Ilsan, South Korea

Sejong Chungnam National University Hospital

Sejong, South Korea

Seoul National University Boramae Medical Center

Seoul, South Korea

The Catholic university of Korea, ST. Vincent's Hospital

Suwon, South Korea

Uijeongbu Eulji Medical Center

Uijeongbu-si, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06177743

Related Trials

OPTIMIZE-APT: Tailored Versus Conventional Antiplatelet Therapy After Intravascular Imaging-guided Drug-eluting Stent Implantation

NCT0541855633 locations

IRIS-Coroflex NEO Cohort

Conditions

Summary

Eligibility

Plain Language Summary

Interventions

Locations(11)

Related Trials

OPTIMIZE-APT: Tailored Versus Conventional Antiplatelet Therapy After Intravascular Imaging-guided Drug-eluting Stent Implantation

MIECC vs Conventional Cardiopulmonary Bypass and Systemic Inflammation in CABG

Product Surveillance Registry

Saphenous Vein as Y-composite Versus Aortocoronary Conduit for CABG

PCCT-Defined High-Risk Plaque and Future Coronary Events: The PREDICT Study